ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 26.63.
| Share Price | ₹5,239.1 | Jun 02,2026 |
| Market Cap | ₹62,659.6 Cr | |
| Earnings-TTM | ₹2,353.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 26.63x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹62,659.6 Cr] as on Jun 02,2026
(/) Earnings [ ₹2,353.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 26.63x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 26.63 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 29.66x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,353.13 | 26.63 | 62,659.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 37.14 | 429,469.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 67.49 | 173,305.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 68.29 | 146,014.0 |
| CIPLA LTD | 3,869.79 | 28.78 | 111,388.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.67 | 106,381.0 |
| MANKIND PHARMA LTD | 1,926.41 | 49.27 | 94,907.2 |
| LUPIN LTD | 5,355.47 | 19.21 | 102,853.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.57 | 108,397.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 23.49 | 82,241.6 |
| LAURUS LABS LTD | 889.85 | 83.92 | 74,673.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.21x |
| Max industry PE | 83.92x |
| Median industry PE | 28.78x |
| Average industry PE | 41.04x |
You may also like the below Video Courses